A new inspection protocol project FDA officials have been discussing at recent conferences could help the agency discern differences in the state of quality among pharmaceutical manufacturing facilities and reward the better ones with reduced oversight.
The project, a collaboration between the agency’s Center for Drug Evaluation and Research and its field organization, the Office of...